Related Experiment Video

Updated: Dec 17, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K

Doxycycline as a potential partner of COVID-19 therapies

Alexandre E Malek1, Bruno P Granwehr1, Dimitrios P Kontoyiannis1

  • 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Idcases
|June 23, 2020
PubMed

Insights

Repurposing existing drugs like doxycycline may offer new COVID-19 treatments. Doxycycline shows promise in reducing inflammation and preventing lung damage, potentially aiding recovery from the novel coronavirus disease.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Immunology

Background:

  • The limited efficacy of current antiviral treatments for Coronavirus disease 2019 (COVID-19) necessitates exploring alternative therapeutic strategies.
  • Drug repurposing presents a viable approach to accelerate the availability of effective COVID-19 treatments, bypassing lengthy de novo drug development.

Discussion:

  • Doxycycline exhibits potential antiviral and anti-inflammatory properties beneficial for COVID-19 management.
  • Its mechanism may involve dampening the cytokine storm, a key factor in severe COVID-19 pathogenesis.
  • Combined with hydroxychloroquine or other agents, doxycycline could offer a synergistic therapeutic effect.

Key Insights:

  • Doxycycline's anti-inflammatory action can mitigate lung damage associated with COVID-19.
  • The repurposing of doxycycline presents a cost-effective and rapid strategy for COVID-19 treatment.
  • Further clinical investigation is warranted to validate doxycycline's efficacy in COVID-19 patients.

Outlook:

  • Exploring combination therapies involving doxycycline could lead to improved clinical outcomes for COVID-19.
  • This research highlights the importance of investigating existing drugs for novel applications in infectious disease outbreaks.
  • Future studies should focus on randomized controlled trials to confirm the safety and effectiveness of doxycycline-based COVID-19 treatments.
Keywords:
2019 novel coronavirusCOVID-19DoxycyclineHydroxychloroquineRemdesivir

More Related Videos

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds10:49

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds

Published on: August 21, 2021

4.8K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.2K

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
834
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
811
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
881
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.1K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
144